Guillaume Wettstein
49 works · 1,951 citations · h-index 16
Top works
- Dual Role of Heat Shock Proteins as Regulators of Apoptosis and Innate Immunity
- Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
- Heat Shock Proteins: Cell Protection through Protein Triage
- Small heat shock proteins and the cytoskeleton: An essential interplay for cell integrity?
- Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation
- The new‐generation pan‐peroxisome proliferator‐activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis
- Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
- Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles
- Design, Synthesis, and Evaluation of a Novel Series of Indole Sulfonamide Peroxisome Proliferator Activated Receptor (PPAR) α/γ/δ Triple Activators: Discovery of Lanifibranor, a New Antifibrotic Clinical Candidate
- Transactivation of the Epidermal Growth Factor Receptor by Heat Shock Protein 90 via Toll-like Receptor 4 Contributes to the Migration of Glioblastoma Cells
- RETRACTED: Extracellular HSP27 mediates angiogenesis through Toll‐like receptor 3
- The small heat‐shock protein α B ‐crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis
- Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity
- Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
- Repetitive DNA sequences include retrotransposons in genomes of the Glomeromycota
- Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin
- The New Generation Pan-Ppar Agonist Iva337 Protects the Liver from Metabolic Disorders and Fibrosis
- Rôle de la cellule mésothéliale dans la genèse de la fibrose pulmonaire idiopathique ?
- Altered liver sinusoidal endothelial cells in MASLD and their evolution following lanifibranor treatment
- The pan-PPAR agonist Lanifibranor improves increased portal pressure, endothelial dysfunction and liver histology in a rat model of early NAFLD